Elevatus Welath Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$967K Buy
3,808
+2,329
+157% +$543K 0.24% 87
2026
Q1
$361K Sell
1,479
-39
-3% -$9.08K 0.19% 91
2025
Q4
$314K Sell
1,518
-21
-1% -$4.15K 0.09% 117
2025
Q3
$285K Buy
1,539
+6
+0.4% +$1.03K 0.08% 100
2025
Q2
$234K Buy
1,533
+5
+0.3% +$769 0.08% 105
2025
Q1
$253K Buy
1,528
+5
+0.3% +$782 0.14% 81
2024
Q4
$220K Buy
1,523
+113
+8% +$17.5K 0.08% 97
2024
Q3
$228K Hold
1,410
0.07% 89
2024
Q2
$206K Sell
1,410
-8
-0.6% -$1.19K 0.08% 101
2024
Q1
$224K Buy
1,418
+5
+0.4% +$796 0.09% 83
2023
Q4
$222K Sell
1,413
-389
-22% -$59.6K 0.1% 82
2023
Q3
$281K Buy
1,802
+406
+29% +$67K 0.25% 49
2023
Q2
$231K Buy
+1,396
New +$225K 0.16% 45

Other funds holding JNJ

Elevatus Welath Management's JNJ Position: Q2 2026 in Review

Elevatus Welath Management increased its Johnson & Johnson (JNJ) stake by 157% in Q2 2026, buying an estimated $543K and bringing the position to 3,808 shares worth $967K. The position accounts for 0.24% of the portfolio, ranked #87.

Elevatus Welath Management first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Elevatus Welath Management held 3,808 shares of Johnson & Johnson worth $967K as of Q2 2026.
  • Elevatus Welath Management bought 2,329 Johnson & Johnson shares in Q2 2026, an estimated $543K.
  • Johnson & Johnson made up 0.24% of Elevatus Welath Management's portfolio in Q2 2026, its #87 holding.
  • Elevatus Welath Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.